KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
45 hedge funds and large institutions have $62.9M invested in Kindred Biosciences, Inc. in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
45
Holding in Top 10
–
Calls
$42K
Puts
–
Top Buyers
| 1 | +$2.8M | |
| 2 | +$1.52M | |
| 3 | +$274K | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$151K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$74.4K |
Top Sellers
| 1 | -$638K | |
| 2 | -$422K | |
| 3 | -$379K | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$314K |
| 5 |
Goldman Sachs
New York
|
-$304K |